Peptable

Comparison

Selank vs Thymosin Alpha-1

Function

While Selank is a peptide developed in Russia as an anxiolytic and nootropic; in animal models it reduces anxiety-like behavior and modulates immune parameters under stress39, Thymosin Alpha-1 is clinically used in some countries as an immunomodulator for chronic hepatitis B/C and as an adjuvant in cancer therapy, enhancing cell-mediated immunity41487.

Mechanism

While Selank works as a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, that combines a tuftsin fragment with a Pro-Gly-Pro motif and is reported to modulate GABAergic neurotransmission and cytokine balance while being resistant to proteolytic degradation39, Thymosin Alpha-1 is a 28-amino-acid thymic peptide fragment of prothymosin alpha that activates dendritic cells and T cells primarily via TLR9/MyD88/NF-κB signaling, enhancing Th1 responses and NK-cell cytotoxicity414.

Receptor

Selank

Not clearly established in the current dataset.

Thymosin Alpha-1

Toll-like receptors, predominantly TLR9 (and also TLR2/TLR3) on plasmacytoid dendritic cells and other immune cells4

Organism or Origin

Selank

Synthetic analog of the IgG-derived tetrapeptide tuftsin39

Thymosin Alpha-1

Endogenous fragment of human prothymosin alpha produced in the thymus1487

Gene

Selank

Not assigned in the current dataset.

Thymosin Alpha-1

PTMA

Summary

Both peptides fall into a similar broad context as Immune-modulating peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Immunology and inflammation contexts, while Selank is more of a neuropeptide and Thymosin Alpha-1 is better described as a cytokine peptide. Both appear to work through Signaling modulator, but the functional emphasis still separates, with Selank leaning toward Anxiolytic and sleep modulation and Thymosin Alpha-1 leaning toward Anti-inflammatory. Selank has a more synthetic analog origin, while Thymosin Alpha-1 is closer to natural endogenous background and their development context also differs, with Selank approved for Research use only while Thymosin Alpha-1 is approved. Thymosin Alpha-1 incorporates acetylation features that are not part of Selank, while their sequence patterns also diverge, with Selank showing proline-rich features and Thymosin Alpha-1 showing protein-mimetic sequence features.

Related articles

No related articles are linked to these peptides yet.